A

AptaBio Therapeutics Inc
KOSDAQ:293780

Watchlist Manager
AptaBio Therapeutics Inc
KOSDAQ:293780
Watchlist
Price: 9 040 KRW -6.32% Market Closed
Market Cap: 243B KRW

Operating Margin
AptaBio Therapeutics Inc

-618.7%
Current
-10 275%
Average
-4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-618.7%
=
Operating Profit
-19.2B
/
Revenue
3.1B

Operating Margin Across Competitors

No Stocks Found

AptaBio Therapeutics Inc
Glance View

Market Cap
243B KRW
Industry
Biotechnology

Aptabio Therapeutics, Inc. operates as a pharmaceutical biotechnology company that develops intractable innovative drugs based on original platform technology. The company is headquartered in Yongin, Gyeonggi-Do and currently employs 28 full-time employees. The company went IPO on 2019-06-12. The firm is developing anti-cancer drugs, drugs for inflammatory and fibrotic diseases and diabetic complications drugs, among others.

Intrinsic Value
893.51 KRW
Overvaluation 90%
Intrinsic Value
Price
A
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-618.7%
=
Operating Profit
-19.2B
/
Revenue
3.1B
What is the Operating Margin of AptaBio Therapeutics Inc?

Based on AptaBio Therapeutics Inc's most recent financial statements, the company has Operating Margin of -618.7%.

Back to Top